Project Details
Generation, molecular characteristics and effector mechanisms of CSF2+ T cells in GvHD (B03)
Subject Area
Immunology
Gastroenterology
Clinical Immunology and Allergology
Medical Microbiology and Mycology, Hygiene, Molecular Infection Biology
Gastroenterology
Clinical Immunology and Allergology
Medical Microbiology and Mycology, Hygiene, Molecular Infection Biology
Term
since 2018
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 324392634
Based on our preliminary work we hypothesize that distinct microbial signatures foster a subtle immunological milieu shift thereby promoting CSF2+ T cell-mediated GvHD. To test this systematically, we link immune, microbial and clinical profiles of CSF2-driven intestinal pathology in preclinical models. Moreover, we perform in depth characterizations of blood and gut CSF-2+ T cells in ASCT patients to explore the mechanisms of T cell differentiation. Lastly, our microbiome analysis seeks to identify drivers of CSF2 in ASCT patients. Overall, we aim to identify key mechanisms underlying CSF2+ T cell driven GvHD.
DFG Programme
CRC/Transregios
Subproject of
TRR 221:
Modulation of graft-versus-host and graft-versus-leukemia immune responses after allogeneic stem cell transplantation
Applicant Institution
Universität Regensburg
Project Heads
Professor Dr. Kai Hildner; Professorin Dr. Christiane Krystelle Nganou Makamdop, since 1/2026
